Written by
Mustafa Çelik
Mustafa Çelik Liv Hospital Content Team
Medically reviewed by

Related Doctors

Assoc. Prof. MD. Evrim Duman Liv Hospital Ulus Assoc. Prof. MD. Evrim Duman Radiation Oncology Asst. Prof. MD. Meltem Topalgökçeli Selam Liv Hospital Ulus Asst. Prof. MD. Meltem Topalgökçeli Selam Medical Oncology Prof. MD. Duygu Derin Liv Hospital Ulus Prof. MD. Duygu Derin Medical Oncology Prof. MD. Emre Merdan Fayda Liv Hospital Ulus Prof. MD. Emre Merdan Fayda Radiation Oncology Prof. MD. Meral Günaldı Liv Hospital Ulus Prof. MD. Meral Günaldı Medical Oncology Assoc. Prof. MD. Murat Ayhan Liv Hospital Vadistanbul Assoc. Prof. MD. Murat Ayhan Medical Oncology Prof. MD.  Itır Şirinoğlu Demiriz Liv Hospital Vadistanbul Prof. MD. Itır Şirinoğlu Demiriz Hematology Prof. MD. Tülin Tıraje Celkan Liv Hospital Vadistanbul Prof. MD. Tülin Tıraje Celkan Pediatric Hematology and Oncology Assoc. Prof. MD. Erkan Kayıkçıoğlu Liv Hospital Bahçeşehir Assoc. Prof. MD. Erkan Kayıkçıoğlu Medical Oncology Assoc. Prof. MD. Mine Dağgez Liv Hospital Bahçeşehir Assoc. Prof. MD. Mine Dağgez Gynecological Oncology Assoc. Prof. MD. Ozan Balakan Liv Hospital Bahçeşehir Assoc. Prof. MD. Ozan Balakan Medical Oncology MD. Taylan Bükülmez Liv Hospital Bahçeşehir MD. Taylan Bükülmez Radiation Oncology Op. MD. Alp Koray Kinter Liv Hospital Bahçeşehir Op. MD. Alp Koray Kinter Gynecological Oncology Prof. MD. Nuri Faruk Aykan Liv Hospital Bahçeşehir Prof. MD. Nuri Faruk Aykan Medical Oncology Prof. MD. Yasemin Altuner Torun Liv Hospital Bahçeşehir Prof. MD. Yasemin Altuner Torun Pediatric Hematology and Oncology Spec. MD. Vildan Kayku Liv Hospital Bahçeşehir Spec. MD. Vildan Kayku Medical Oncology Spec. MD. Özlem Doğan Liv Hospital Bahçeşehir Spec. MD. Özlem Doğan Medical Oncology Assoc. Prof. MD. Emir Çelik Liv Hospital Topkapı Assoc. Prof. MD. Emir Çelik Medical Oncology Assoc. Prof. MD. Muhammed Mustafa Atcı Liv Hospital Topkapı Assoc. Prof. MD. Muhammed Mustafa Atcı Medical Oncology Prof. MD. İrfan Çiçin Liv Hospital Topkapı Prof. MD. İrfan Çiçin Medical Oncology Assoc. Prof. MD.  Ramazan Öcal Liv Hospital Ankara Assoc. Prof. MD. Ramazan Öcal Hematology Assoc. Prof. MD. Nazlı Topfedaisi Özkan Liv Hospital Ankara Assoc. Prof. MD. Nazlı Topfedaisi Özkan Gynecological Oncology Prof. MD. Fikret Arpacı Liv Hospital Ankara Prof. MD. Fikret Arpacı Medical Oncology Prof. MD. Gökhan Erdem Liv Hospital Ankara Prof. MD. Gökhan Erdem Medical Oncology Prof. MD. Meral Beksaç Liv Hospital Ankara Prof. MD. Meral Beksaç Hematology Prof. MD. Oral Nevruz Liv Hospital Ankara Prof. MD. Oral Nevruz Hematology Prof. MD. Saadettin Kılıçkap Liv Hospital Ankara Prof. MD. Saadettin Kılıçkap Medical Oncology Prof. MD. Sadık Muallaoğlu Liv Hospital Ankara Prof. MD. Sadık Muallaoğlu Medical Oncology Spec. MD. Ender Kalacı Liv Hospital Ankara Spec. MD. Ender Kalacı Medical Oncology Assoc. Prof. MD. Fadime Ersoy Dursun Liv Hospital Gaziantep Assoc. Prof. MD. Fadime Ersoy Dursun Hematology Prof. MD. Fatih Teker Liv Hospital Gaziantep Prof. MD. Fatih Teker Medical Oncology Spec. MD. ELXAN MEMMEDOV Liv Bona Dea Hospital Bakü Spec. MD. ELXAN MEMMEDOV Medical Oncology Spec. MD. Ceyda Aslan Spec. MD. Ceyda Aslan Hematology Spec. MD. Elkhan Mammadov Spec. MD. Elkhan Mammadov Medical Oncology Spec. MD. Elmir İsrafilov Spec. MD. Elmir İsrafilov Hematology Spec. MD. Minure Abışova Eliyeva Spec. MD. Minure Abışova Eliyeva Hematology Spec. MD. Natavan Azizova Spec. MD. Natavan Azizova Medical Oncology Prof. MD. Mehmet Hilmi Doğu Liv Hospital Ulus + Liv Hospital Bahçeşehir Prof. MD. Mehmet Hilmi Doğu Hematology
...
Views
Read Time
...
views
Read Time
What Is PSA Screening? Types, Results & Next Steps.
What Is PSA Screening? Types, Results & Next Steps. 4

Understanding your health can be tough, but making informed choices is key to staying well. Prostate cancer is a big concern for men, with 30% of new cases in 2025. This year, over 313,000 men will be diagnosed. Knowing your options is more important than ever.

Learn how the PSA screening test has contributed to a 50% decline in prostate cancer mortality rates.

Many wonder, what is the check for prostate cancer? This test finds problems early, before symptoms show. It uses a blood test to check your health. We’re here to help you through it all with evidence-based protocols.

Learning what is the screening test for prostate cancer lets you take charge of your health. Whether it’s for a routine check or more detailed tests, we’re here for you. We focus on your comfort and peace of mind, with top-notch medical care.

Key Takeaways

  • Prostate cancer accounts for 30% of male cancer diagnoses in 2025.
  • Early detection significantly improves outcomes for patients.
  • The procedure involves a simple blood analysis to monitor specific markers.
  • We provide evidence-based guidance to help you interpret your results.
  • Proactive health management is essential for long-term wellness.

Understanding the PSA Screening Test and Its Clinical Impact

Apr 1516 image 1 1 LIV Hospital
What Is PSA Screening? Types, Results & Next Steps. 5

Knowing how PSA testing works is key to making smart choices. When you get a blood test for prostate cancer screening, it’s good to understand the science. This knowledge helps you take charge of your health.

The Role of Prostate-Specific Antigen in Cancer Detection

The prostate-specific antigen (PSA) is a protein made by both healthy and cancerous prostate cells. When we do p, sa screening for prostate cancer, we check the PSA levels in your blood. High levels might mean you need to see a doctor.

Roate tests are key in finding cancer early. By using sa testing for prostate cancer, doctors can spot problems before symptoms show up. This is a big part of why rostate cancer screening tools are so important for men.

Statistical Evidence for Screening Efficacy

Studies show that the rostate screening test has made a big difference. From 1992 to 2023, deaths from prostate cancer went down by over 50%. Most of this drop is thanks to PSA testing.

Studies like one from Kaiser Permanente show how important screening is. It found that annual tests for men 55 to 75 cut prostate cancer deaths by 64%. Another study in Europe found that screening saves about 22 lives for every 10,000 men.

MetricImpact of ScreeningClinical Outcome
Mortality ReductionUp to 64%Significant
Death Prevention22 per 10,000High Efficacy
Primary ToolPSA Blood TestStandardized

Interpreting Results and Navigating Next Steps

Interpreting Results and Navigating Next Steps
What Is PSA Screening? Types, Results & Next Steps. 6

Understanding your screening data is a journey we take with you. It’s about feeling informed and supported. When you get a prostate cancer check, the lab report gives you specific numbers. We help you make sense of these numbers and what they mean for your health.

Understanding PSA Thresholds and Abnormal Levels

The main thing in your report is the prostate-specific antigen (PSA) level in your blood. If it’s over 4.0 ng/mL, it might mean you need more tests. But remember, a high PSA doesn’t always mean you have cancer.

Many things can affect your PSA levels, like your age, prostate size, and how active you’ve been. So, we see the prostate cancer test as a starting point, not a final say. Context is everything when looking at your health.

Differentiating Between Total and Free PSA

Your doctor might look at different types of psa to get a better picture. They compare psa and free psa levels to tell if you have a serious issue or not. This free vs total psa ratio is a key indicator.

Consulting with Healthcare Providers on Prostate Cancer Screening Options

When you get a prostate cancer checkup, you start talking about your health long-term. It’s important to talk about all prostate cancer screening options with your doctor. If your results are high, they might suggest more tests.

Here are some steps to take when looking at your results:

  • Look at your PSA levels over time to see any trends.
  • Talk to your doctor about the test prostate cancer plans that fit your age and risk.
  • Remember, a biopsy is the only way to confirm any findings.

We encourage you to stay proactive and ask questions. Your health is important, and making informed choices is key to good care.

Conclusion

Starting your wellness journey begins with making informed choices about prostate cancer screening. We aim to help you understand your options so you can talk to your doctor about what’s best for you.

Choosing to screen for prostate cancer is a personal decision. It depends on your risk factors and what you hope to gain from screening. We suggest you discuss your health history and what you want with your doctor. This way, your screening plan will match your health goals.

Regular check-ups are key to keeping you healthy. By working closely with your healthcare team, you’re taking a big step towards a healthier future. We’re committed to supporting you with top-notch care and advice at every step.

If you need more help, contact our specialists at Medical organization or Medical organization. Our team is ready to offer the help you need. Your health is our top concern, and we’re here to guide you through these important decisions.

FAQ

What is the screening test for prostate cancer and how does it function?

The main screening test for prostate cancer is the PSA blood test, often combined with a digital rectal exam (DRE). It works by measuring prostate-specific antigen levels, which may rise due to cancer, enlargement, or inflammation.

How is prostate cancer screening done during a standard medical appointment?

A clinician typically reviews risk factors, orders a PSA blood test, and may perform a digital rectal exam. These steps help assess prostate size, texture, and possible abnormalities.

What is the clinical difference between free vs total PSA?

Total PSA measures all PSA in the blood, while free PSA measures the unbound portion. A lower free-to-total PSA ratio can sometimes suggest a higher risk of prostate cancer.

What are the various types of PSA results that doctors monitor?

Doctors monitor total PSA levels, free PSA, PSA velocity (rate of change over time), and PSA density (PSA relative to prostate size). These help refine risk assessment.

What is the check for prostate cancer if my PSA levels are elevated?

If PSA is elevated, doctors may repeat the test, perform imaging like MRI, and recommend a prostate biopsy if cancer is suspected. Further evaluation depends on overall risk and trends.

Why is PSA testing for prostate cancer considered so vital for modern men’s health?

PSA testing helps detect prostate cancer early, often before symptoms appear, when treatment is more effective. It also assists in monitoring disease progression or recurrence.

What should I expect during a prostate cancer screening test at your facility?

You can expect a brief consultation, a blood draw for PSA testing, and possibly a physical exam if indicated. The process is generally quick and minimally invasive.

References:

National Center for Biotechnology Information. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7856610/

i

Medical Disclaimer

The content on this page is for informational purposes only and is not a substitute for professional medical advice, diagnosis or treatment. Always consult a qualified healthcare provider regarding any medical conditions.

Book a Free Certified Online
Doctor Consultation

Clinics/branches
GDPR

We're Here to Help.
Get in Touch

Send us all your questions or requests, and our
expert team will assist you.

Our Doctors

Assoc. Prof. MD. Evrim Duman Radiation Oncology

Assoc. Prof. MD. Evrim Duman

Liv Hospital Ulus
Asst. Prof. MD. Meltem Topalgökçeli Selam Medical Oncology

Asst. Prof. MD. Meltem Topalgökçeli Selam

Liv Hospital Ulus
Prof. MD. Duygu Derin Medical Oncology

Prof. MD. Duygu Derin

Liv Hospital Ulus
Prof. MD. Emre Merdan Fayda Radiation Oncology

Prof. MD. Emre Merdan Fayda

Liv Hospital Ulus
Prof. MD. Mehmet Hilmi Doğu Hematology

Prof. MD. Mehmet Hilmi Doğu

Liv Hospital Ulus
Liv Hospital Bahçeşehir
Prof. MD. Meral Günaldı Medical Oncology

Prof. MD. Meral Günaldı

Liv Hospital Ulus
Assoc. Prof. MD. Murat Ayhan Medical Oncology

Assoc. Prof. MD. Murat Ayhan

Liv Hospital Vadistanbul
Prof. MD.  Itır Şirinoğlu Demiriz Hematology

Prof. MD. Itır Şirinoğlu Demiriz

Liv Hospital Vadistanbul
Prof. MD. Tülin Tıraje Celkan Pediatric Hematology and Oncology

Prof. MD. Tülin Tıraje Celkan

Liv Hospital Vadistanbul
Assoc. Prof. MD. Erkan Kayıkçıoğlu Medical Oncology

Assoc. Prof. MD. Erkan Kayıkçıoğlu

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Mine Dağgez Gynecological Oncology

Assoc. Prof. MD. Mine Dağgez

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Ozan Balakan Medical Oncology

Assoc. Prof. MD. Ozan Balakan

Liv Hospital Bahçeşehir
MD. Taylan Bükülmez Radiation Oncology

MD. Taylan Bükülmez

Liv Hospital Bahçeşehir
Op. MD. Alp Koray Kinter Gynecological Oncology

Op. MD. Alp Koray Kinter

Liv Hospital Bahçeşehir
Prof. MD. Nuri Faruk Aykan Medical Oncology

Prof. MD. Nuri Faruk Aykan

Liv Hospital Bahçeşehir
Prof. MD. Yasemin Altuner Torun Pediatric Hematology and Oncology

Prof. MD. Yasemin Altuner Torun

Liv Hospital Bahçeşehir
Spec. MD. Vildan Kayku Medical Oncology

Spec. MD. Vildan Kayku

Liv Hospital Bahçeşehir
Spec. MD. Özlem Doğan Medical Oncology

Spec. MD. Özlem Doğan

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Emir Çelik Medical Oncology

Assoc. Prof. MD. Emir Çelik

Liv Hospital Topkapı
Assoc. Prof. MD. Muhammed Mustafa Atcı Medical Oncology

Assoc. Prof. MD. Muhammed Mustafa Atcı

Liv Hospital Topkapı
Prof. MD. İrfan Çiçin Medical Oncology

Prof. MD. İrfan Çiçin

Liv Hospital Topkapı
Assoc. Prof. MD.  Ramazan Öcal Hematology

Assoc. Prof. MD. Ramazan Öcal

Liv Hospital Ankara
Assoc. Prof. MD. Nazlı Topfedaisi Özkan Gynecological Oncology

Assoc. Prof. MD. Nazlı Topfedaisi Özkan

Liv Hospital Ankara
Prof. MD. Fikret Arpacı Medical Oncology

Prof. MD. Fikret Arpacı

Liv Hospital Ankara
Prof. MD. Gökhan Erdem Medical Oncology

Prof. MD. Gökhan Erdem

Liv Hospital Ankara
Prof. MD. Meral Beksaç Hematology

Prof. MD. Meral Beksaç

Liv Hospital Ankara
Prof. MD. Oral Nevruz Hematology

Prof. MD. Oral Nevruz

Liv Hospital Ankara
Prof. MD. Saadettin Kılıçkap Medical Oncology

Prof. MD. Saadettin Kılıçkap

Liv Hospital Ankara
Prof. MD. Sadık Muallaoğlu Medical Oncology

Prof. MD. Sadık Muallaoğlu

Liv Hospital Ankara
Spec. MD. Ender Kalacı Medical Oncology

Spec. MD. Ender Kalacı

Liv Hospital Ankara
Assoc. Prof. MD. Fadime Ersoy Dursun Hematology

Assoc. Prof. MD. Fadime Ersoy Dursun

Liv Hospital Gaziantep
Prof. MD. Fatih Teker Medical Oncology

Prof. MD. Fatih Teker

Liv Hospital Gaziantep
Spec. MD. ELXAN MEMMEDOV Medical Oncology

Spec. MD. ELXAN MEMMEDOV

Liv Bona Dea Hospital Bakü
Spec. MD. Ceyda Aslan Hematology

Spec. MD. Ceyda Aslan

Spec. MD. Elkhan Mammadov Medical Oncology

Spec. MD. Elkhan Mammadov

Spec. MD. Elmir İsrafilov Hematology

Spec. MD. Elmir İsrafilov

Spec. MD. Minure Abışova Eliyeva Hematology

Spec. MD. Minure Abışova Eliyeva

Spec. MD. Natavan Azizova Medical Oncology

Spec. MD. Natavan Azizova

Need Help? Chat with our medical team

Let's Talk on WhatsApp

📌

Get instant answers from our medical team. No forms, no waiting — just tap below to start chatting now.

or call us at +90 530 174 28 17